Class information for:
Level 1: HODGKINS DISEASE//HODGKIN LYMPHOMA//HODGKINS LYMPHOMA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
996 2912 33.4 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
118 3       EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE 69002
109 2             CHRONIC LYMPHOCYTIC LEUKEMIA//HODGKINS DISEASE//MANTLE CELL LYMPHOMA 25223
996 1                   HODGKINS DISEASE//HODGKIN LYMPHOMA//HODGKINS LYMPHOMA 2912

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HODGKINS DISEASE authKW 1457412 20% 24% 575
2 HODGKIN LYMPHOMA authKW 788824 10% 26% 295
3 HODGKINS LYMPHOMA authKW 528083 7% 24% 206
4 BRENTUXIMAB VEDOTIN authKW 241335 2% 43% 53
5 ABVD authKW 231468 1% 60% 37
6 INVOLVED NODE RADIOTHERAPY authKW 136992 0% 93% 14
7 GERMAN HODGKIN STUDY GRP address 133703 1% 51% 25
8 BEACOPP authKW 116524 1% 65% 17
9 INVOLVED FIELD RADIOTHERAPY authKW 115304 1% 50% 22
10 HODGKIN authKW 95428 1% 23% 39

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 46894 65% 0% 1887
2 Hematology 23582 28% 0% 807
3 Radiology, Nuclear Medicine & Medical Imaging 2733 13% 0% 375
4 Medicine, General & Internal 1038 10% 0% 298
5 Transplantation 543 3% 0% 94
6 Pediatrics 327 5% 0% 136
7 Immunology 20 3% 0% 96
8 MEDICINE, MISCELLANEOUS 5 0% 0% 1
9 Education, Scientific Disciplines 2 0% 0% 10
10 Cell & Tissue Engineering 1 0% 0% 4

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GERMAN HODGKIN STUDY GRP 133703 1% 51% 25
2 GHSG 84567 0% 73% 11
3 GERMAN HODGKINS LYMPHOMA STUDY GRP 52421 0% 100% 5
4 BIOSTAT MED INFORMAT SYST 20968 0% 100% 2
5 GLOBAL ONCOL PRICING MARKET ACCESS HLTH ECON 20968 0% 100% 2
6 LYMPHOMA TUMOR GRP 20968 0% 100% 2
7 COCHRANE HAEMATOL MALIGNANCIES GRP 18054 0% 19% 9
8 RADIAT ONCOL 15771 11% 0% 317
9 YORKSHIRE CANC UNIT CLIN ONCOL 15245 0% 36% 4
10 IST CLIN ONCOL 13978 0% 67% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANNALS OF ONCOLOGY 50897 7% 2% 200
2 JOURNAL OF CLINICAL ONCOLOGY 47096 9% 2% 270
3 LEUKEMIA & LYMPHOMA 23561 4% 2% 131
4 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 17377 6% 1% 170
5 HAEMATOLOGICA 8978 2% 2% 56
6 CANCER 8050 5% 1% 147
7 CANCER TREATMENT REPORTS 7931 1% 2% 41
8 HEMATOLOGICAL ONCOLOGY 7624 1% 3% 25
9 CURRENT HEMATOLOGIC MALIGNANCY REPORTS 6538 0% 4% 14
10 EUROPEAN JOURNAL OF HAEMATOLOGY 4782 1% 1% 42

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 HODGKINS DISEASE 1457412 20% 24% 575 Search HODGKINS+DISEASE Search HODGKINS+DISEASE
2 HODGKIN LYMPHOMA 788824 10% 26% 295 Search HODGKIN+LYMPHOMA Search HODGKIN+LYMPHOMA
3 HODGKINS LYMPHOMA 528083 7% 24% 206 Search HODGKINS+LYMPHOMA Search HODGKINS+LYMPHOMA
4 BRENTUXIMAB VEDOTIN 241335 2% 43% 53 Search BRENTUXIMAB+VEDOTIN Search BRENTUXIMAB+VEDOTIN
5 ABVD 231468 1% 60% 37 Search ABVD Search ABVD
6 INVOLVED NODE RADIOTHERAPY 136992 0% 93% 14 Search INVOLVED+NODE+RADIOTHERAPY Search INVOLVED+NODE+RADIOTHERAPY
7 BEACOPP 116524 1% 65% 17 Search BEACOPP Search BEACOPP
8 INVOLVED FIELD RADIOTHERAPY 115304 1% 50% 22 Search INVOLVED+FIELD+RADIOTHERAPY Search INVOLVED+FIELD+RADIOTHERAPY
9 HODGKIN 95428 1% 23% 39 Search HODGKIN Search HODGKIN
10 INFRADIAPHRAGMATIC 77199 0% 82% 9 Search INFRADIAPHRAGMATIC Search INFRADIAPHRAGMATIC

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 PERALES, MA , CEBERIO, I , ARMAND, P , BURNS, LJ , CHEN, R , COLE, PD , EVENS, AM , LAPORT, GG , MOSKOWITZ, CH , POPAT, U , ET AL (2015) ROLE OF CYTOTOXIC THERAPY WITH HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF HODGKIN LYMPHOMA: GUIDELINES FROM THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 21. ISSUE 6. P. 971 -983 120 72% 9
2 EGHBALI, H , SOUBEYRAN, P , TCHEN, N , DE MASCAREL, I , SOUBEYRAN, I , RICHAUD, P , (2000) CURRENT TREATMENT OF HODGKIN'S DISEASE.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 35. ISSUE 1. P. 49 -73 176 72% 3
3 FRANKLIN, JG , PAUS, MD , PLUETSCHOW, A , SPECHT, L , (2005) CHEMOTHERAPY, RADIOTHERAPY AND COMBINED MODALITY FOR HODGKIN'S DISEASE, WITH EMPHASIS ON SECOND CANCER RISK.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - 97 93% 15
4 HERTZBERG, M , (2014) RELAPSED/REFRACTORY HODGKIN LYMPHOMA WHAT IS THE BEST SALVAGE THERAPY AND DO WE NEED RIC-ALLOSCT?.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 28. ISSUE 1. P. 123 -+ 81 86% 5
5 ALINARI, L , BLUM, KA , (2016) HOW I TREAT RELAPSED CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANT.BLOOD. VOL. 127. ISSUE 3. P. 287 -295 69 82% 2
6 MARTINO, M , FESTUCCIA, M , FEDELE, R , CONSOLE, G , CIMMINIELLO, M , GAVAROTTI, P , BRUNO, B , (2016) SALVAGE TREATMENT FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA: ROLE OF ALLOGRAFTING, BRENTUXIMAB VEDOTIN AND NEWER AGENTS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 16. ISSUE 3. P. 347 -364 87 71% 0
7 HOPPE, RT , ADVANI, RH , AI, WYZ , AMBINDER, RF , AOUN, P , BELLO, CM , BENITEZ, CM , BIERMAN, PJ , BLUM, KA , CHEN, R , ET AL (2015) HODGKIN LYMPHOMA, VERSION 2.2015.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 13. ISSUE 5. P. 554 -586 77 69% 8
8 KURUVILLA, J , KEATING, A , CRUMP, M , (2011) HOW I TREAT RELAPSED AND REFRACTORY HODGKIN LYMPHOMA.BLOOD. VOL. 117. ISSUE 16. P. 4208 -4217 71 78% 36
9 AISENBERG, AC , (1999) PROBLEMS IN HODGKIN'S DISEASE MANAGEMENT.BLOOD. VOL. 93. ISSUE 3. P. 761 -779 107 69% 102
10 BROCKELMANN, PJ , ENGERT, A , (2015) THE GHSG APPROACH TO TREATING HODGKIN'S LYMPHOMA.CURRENT HEMATOLOGIC MALIGNANCY REPORTS. VOL. 10. ISSUE 3. P. 256 -265 70 80% 0

Classes with closest relation at Level 1


Rank Class id link
1 7168 INTERIM PET//LYMPHOMA//INTERIM PET CT
2 18533 RADIATION INDUCED HEART DISEASE//MEDIASTINAL IRRADIATION//RADIATION INDUCED MYOCARDIAL DAMAGE
3 2610 HODGKINS DISEASE//NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA//HODGKIN LYMPHOMA
4 8127 SECONDARY LEUKEMIA//THERAPY RELATED//THERAPY RELATED LEUKEMIA
5 2606 NON HODGKINS LYMPHOMA//AGGRESSIVE LYMPHOMA//DIFFUSE LARGE B CELL LYMPHOMA
6 22914 CATTADRA CLIN MED 2A//CATTEDRA PATOL MED 1A//PILOT UNIT
7 22504 STOMAL RECURRENCE//SUBGLOTTIC CARCINOMA//SUBGLOTTIC EXTENSION
8 17811 SOLUBLE CD30//CD30//SCD30
9 3867 CHILDHOOD CANCER//CHILDHOOD CANCER SURVIVORS//EPIDEMIOL CANC CONTROL
10 1785 FERTILITY PRESERVATION//ONCOFERTILITY//OVARIAN TRANSPOSITION

Go to start page